| Term 
 
        | What are 3 characteristics of neurodegenerative disorders? |  | Definition 
 
        | 1. loss of neurones 2. progressive
 3. irreversible
 |  | 
        |  | 
        
        | Term 
 
        | Per envy 100,000, how many people are affected by Parkinson's, Huntington's and Alzheimer's disease? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | How many people have Parkinson's, Huntington's and Alzheimer's disease in the UK? |  | Definition 
 
        | P: 120,000 H: 3,000
 A: 700,000
 |  | 
        |  | 
        
        | Term 
 
        | When is the onset of Parkinson's, Huntington's and Alzheimer's disease? |  | Definition 
 
        | P: all ages (1:200 over 70) H: middle life
 A: old age (>60)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | An acquired, persistent intellectual impairment involing at least 3 of the following domains; Language
 Memory
 Visuospatial skills
 Emotion/personality
 Cognitive/executive functions
 |  | 
        |  | 
        
        | Term 
 
        | Which diseases are associated with dementia? |  | Definition 
 
        | Mainly Alzheimers but also Parkinson's and Huntington's. |  | 
        |  | 
        
        | Term 
 
        | Explain the pathology of Alzheimer's |  | Definition 
 
        | Senile plaques. Neurofibrillary tangles
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | extracellular deposits of beta amyloid (a neurotoxic peptide) in the grey matter of the brain. |  | 
        |  | 
        
        | Term 
 
        | What are neurofibrillary tangles? |  | Definition 
 
        | aggregates of hyperphosphorylated tau proteins: proteins that stabilise microtubules. Upon becoming hyperphosphorylated, these tau proteins become defective and no longer stabilise the microtubules adequately. |  | 
        |  | 
        
        | Term 
 
        | Explain the pathology of Parkinson's disease |  | Definition 
 
        | -	These are spherical, eosinophilic (staining of certain tissues, cells, or organelles after they have been washed with eosin, a dye) bodies that contain cellular proteins.
 |  | 
        |  | 
        
        | Term 
 
        | Explain the pathology of progressive supra nuclear palsy |  | Definition 
 
        | subcortical neurofibrillary tangles |  | 
        |  | 
        
        | Term 
 
        | Explain the pathology of cortical basal ganglionic degeneration |  | Definition 
 
        | inclusive bodies in sub cortex and cortical areas |  | 
        |  | 
        
        | Term 
 
        | Explain the pathology of Huntington's disease |  | Definition 
 
        | genetic disorder so can be readily diagnose selective loss of neurone from the striatum
 gliosis in the areas where neurones are lost
 |  | 
        |  | 
        
        | Term 
 
        | Explain the pathology of Pick's disease |  | Definition 
 
        | selected atrophy of the temporal lobe occasionally inclusion bodies (Pick bodies) seen.
 |  | 
        |  | 
        
        | Term 
 
        | Who does Parkinson's disease affect? |  | Definition 
 
        | - the older you are the more likely you are to have it - however does it affect the young
 |  | 
        |  | 
        
        | Term 
 
        | What does it mean that Parkinson's is akinetic? |  | Definition 
 
        | loss of movement increased muscle tone (causes rigidity)
 |  | 
        |  | 
        
        | Term 
 
        | Describe the progression of Parkinson's disease |  | Definition 
 
        | - slow at first (mild inconvenience) - becomes more intrusive
 - remission rare but can be triggered by emotion, fear and excitement
 - 10-15 years but can live for decades longer
 |  | 
        |  | 
        
        | Term 
 
        | How do people with Parkinson's die? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What are the symptoms of Parkinson's disease? (4) |  | Definition 
 
        | 1) tremor 4-7Hz 2) rigidity
 3) speech is slurred, monotone, dribbles and dysphagia comes later
 4) Akinesia
 5) Postural changes
 |  | 
        |  | 
        
        | Term 
 
        | Describe the pathology of Parkinson's disease |  | Definition 
 
        | 1. loss of neuro-melanin neurones in substantial nigra 2. sometimes see Lewy bodies
 3. dopaminergic neurones are affected
 4. loss of nigro-striatal excitatory and inhibitory pathways
 5. basically the degeneration of the midbrain nuclei
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | spherical, intracellular inclusive bodies that are stained well by eosin and contain lots of cellular proteins |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | most cases are idiopathic there are some associated disorders that show Parkinson-ike symptoms
 |  | 
        |  | 
        
        | Term 
 
        | What are the associated disorders? |  | Definition 
 
        | Drug-induced (iatrogenic) MPTP-induced
 Post-encephalitic
 |  | 
        |  | 
        
        | Term 
 
        | How are pathways affected in Parkinson's disease? |  | Definition 
 
        | degeneration of the projections from the substantia nigra to the striatum (caudate nucleus, part of the putamen and part of the globes palladus) |  | 
        |  |